BRIDGEWATER, N.J.--(BUSINESS WIRE)--May 18, 2006--Enzon Pharmaceuticals, Inc., (NASDAQ: ENZN - News) said today that it has priced its previously announced offering of convertible senior notes to certain qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
